Sponsorship, authorship, and accountability

F Davidoff, CD DeAngelis, JM Drazen, J Hoey… - The Lancet, 2001 - thelancet.com
We believe that a sponsor should have the right to review a manuscript for a defined period (eg,
30 to 60 days) before publication to allow for the filing of additional patent protection, if …

Clinical trial registration: looking back and moving ahead

C Laine, R Horton, CD DeAngelis, JM Drazen… - The Lancet, 2007 - thelancet.com
Comment 1910 www. thelancet. com Vol 369 June 9, 2007 require registration, and the
registration of trial results. As is always the case, the ICMJE establishes policy only for the 12 …

Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey

JS Wislar, A Flanagin, PB Fontanarosa, CD DeAngelis - Bmj, 2011 - bmj.com
Objectives To assess the prevalence of honorary and ghost authors in six leading general
medical journals in 2008 and compare this with the prevalence reported by authors of articles …

Guidelines for medical and health information sites on the internet: principles governing AMA web sites

…, J White, K Andrews, RL Kennett, CD DeAngelis… - Jama, 2000 - jamanetwork.com
Access to medical information via the Internet has the potential to speed the transformation
of the patient-physician relationship from that of physician authority ministering advice and …

Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest

…, CD Berkowitz, SC Chimonas, CD DeAngelis… - Jama, 2009 - jamanetwork.com
Professional medical associations (PMAs) play an essential role in defining and advancing
health care standards. Their conferences, continuing medical education courses, practice …

Medical professionalism

CD DeAngelis - Jama, 2015 - jamanetwork.com
least to around 400 BC with the Hippocratic Oath. The words of that oath (or a similar oath)
are taken by virtually every physician at graduation from medical school, and the modern …

Conflict of interest and the public trust

CD DeAngelis - Jama, 2000 - jamanetwork.com
THIS ISSUE OF THE JOURNAL CONTAINS A CLUSTER OF articles that address students’,
residents’, and fac-ulty members’ conflicts of interest with pharmaceutical and other …

Impugning the integrity of medical science: the adverse effects of industry influence

CD DeAngelis, PB Fontanarosa - Jama, 2008 - jamanetwork.com
Two articles1, 2 in this issue of JAMA provide a glimpse of one company’s apparent
misrepresentation of research data and its manipulation of clinical research articles and clinical …

Uniform format for disclosure of competing interests in ICMJE journals

…, F Godlee, FA Frizelle, PW De Leeuw, CD DeAngelis - The Lancet, 2009 - thelancet.com
Disclosure of financial associations of authors of articles published in biomedical journals has
become common practice. The information provided in these disclosures helps the reader …

Postmarketing surveillance—lack of vigilance, lack of trust

PB Fontanarosa, D Rennie, CD DeAngelis - Jama, 2004 - jamanetwork.com
Physicians and patients expect that when medications are prescribed correctly for labeled
indications and are used as directed, these medications generally will have beneficial effects …